drug

(1) Genotyping for CYP4502D6 and 2C19 polymorphisms

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
GENETIC
Pre-approval / investigational in the US
Developed by Gesche Jurgens
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
GENETIC

Indications

Trials

1
Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment
NCT00707382—Completed

KOLs & investigators

1
Gesche Jürgens, MD, phdKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Gesche Jurgens
company
trial
Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment
NA
trial
indication
Schizophrenia
indication
Patient Compliance
indication
Schizophrenia
indication
KOL
Gesche Jürgens, MD, phd
KOL score 5
person